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Three barriers to effective, helpful, and accurate analysis of clinical out-comes for which breakthrough technology has just emerged include: (1)general analysis of repeated follow-up measures, (2) treatment compar-isons from nonrandomized clinical experiences, and (3) scientific riskfactor identification. The three barriers have in common workarounds,that is, unsatisfactory and inadequate temporary, but simple, solutions in
the absence of a real solution. Our expectations may be so low that we run the risk of
preferring the workarounds for their simplicity rather than rejoicing that breakthrough
has occurred! Therefore, the purpose of this article is to acquaint you with the break-
through methods in a nontechnical fashion so that you may read reports more knowl-
edgeably, interact with your statistical collaborators more closely, or encourage your sta-
tistician to consider these methods if they are applicable to your clinical research.
Barriers
Follow-up Assessment
Clinical question: How does aortic valve regurgitation progress after heart valve
replacement with a bioprosthesis, and what factors influence that change?
Available data: Aortic regurgitation grade (0 to 4+) by echocardiography at peri-
odic clinic visits.
Simple workaround: Tabulation of aortic regurgitation grade at latest clinic visit.
Simple. But it does not answer the question!
Attempts have been made to depict the time-related change in graded outcomes
after cardiac surgery, but the display appears complex at first glance. Even those
attempts used the status only at last follow-up, not the status assessed periodically
across time.1,2
Clinical question: How do pressure gradients across bioprostheses progress with
time?
Available data: Echocardiographic estimates of pressure gradient at irregular
clinic visits.
Simple workaround: Lacking methods to analyze serial echocardiographic data,
we simply provide a global mean value. We may go a bit further and group the mea-
surements into a few time intervals, then average all values within those intervals,
perhaps stratified by prosthesis size.
Simple, but just as in the case of repeated assessment of functional status, the
workaround does not accurately answer the question.
We know that the assessments are made at uneven time intervals, that multiple
measurements made in a single patient are more highly correlated with one anoth-
er than those between patients, and that death, or valve explantation, or transplan-
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stance of many clinical investigations. Yet, two different ana-
lysts looking at the same data set often identify different risk
factors.4-6 In addition to inconsistent findings, automated com-
puter algorithms often are used to assist (or even perform)
multivariable analyses in a stepwise fashion. This practice is
generally condemned by statisticians.
Fortunately for scientific variable selection, a breakthrough
technology now exists that not only identifies risk factors from
a carefully constructed, medically informed set of variables,
but also quantifies the reliability of that identification. You
need to understand this technology better.
Breakthrough Technologies
Analyzing Censored Repeatedly Assessed Time-Related
Data
In 1972, D. R. Cox introduced breakthrough technology for
multivariable analysis of time-related events.7 During the
1980s, textbooks on survival analysis proliferated. In analysis
of time-related events, the event is assumed to be a “point
process”; that is, it is assumed to occur at some specific point
in time, and the analysis focuses on the distribution of times
until that event occurs.
A number of phenomena of equal importance to the car-
diothoracic surgeon are not point processes, but rather they
continually evolve across time. That evolution may be
assessed on a continuous scale or on a semicontinuous ordered
scale. Examples include time-related change in New York
Heart Association functional class after a Dor procedure,
degree of return of valvular regurgitation after mitral valve
repair and its progression, change in ventricular volume after
a myocardial infarction, evidence for sensitization after left
ventricular assist device insertion, change in pulmonary func-
tion after single- or double-lung transplantation, or progres-
sion of swallowing difficulty in achalasia.
For all these phenomena, information generally is
obtained from patients periodically, usually at irregular
intervals that differ from patient to patient. Assessment is
interrupted (censored) by death or by cross-sectional fol-
low-up, just as in time-related events studies. Further, the
medical investigator is interested in factors that affect the
longitudinal evolution of these phenomena.
There were severe technologic barriers to comprehensive
analysis of these types of data. Repeated-measures analysis of
variance for continuous variables had restrictive requirements
for clinical data, including the necessity for fixed time intervals
of assessment and lack of provision for censored data. Ordinal
logistic regression for assessment of functional status was useful
for assessments made at cross-sectional follow-up, but not for
repeated assessment at irregular time intervals with censoring.
Breakthrough occurred at Johns Hopkins University in
the late 1980s. Dr Scott Zeger, his students, and colleagues
incrementally, but rapidly, evolved the scope, generality,
and availability of what they termed “longitudinal data
tation, or any of a number of other events may interrupt
obtaining further measurements in some patients (called
censoring). How can we analyze such complex information
in a meaningful, helpful, and accurate way?
Fortunately, for such data, a breakthrough technology
now exists for analyzing censored, repeatedly assessed,
time-related binary (yes/no), ordinal (graded), and continu-
ous outcomes or measurement data. You need to understand
this technology better.
Nonrandomized Treatment Comparison
Clinical question: Is off-pump bypass superior to on-
pump bypass?
Available data: Clinical experience with nonsystematic
selection of bypass technique.
Simple workaround: Simple comparisons of outcome for
each method. We may even attempt to obtain risk-adjusted
estimates of the possible benefit of one technique versus
another by multivariable analysis.
This is simple (or at least somewhat simple), but it does not
directly answer the question as to what other difference in out-
come is attributable directly to difference in technique.
We have grown up with National Institutes of Health–
sponsored, and now largely industry-sponsored, small and
large randomized clinical trials. They are the gold standard for
determining treatment efficacy. A major barrier in using ran-
domized trials as the sole basis for evidence-based clinical
decision-making is that we cannot randomize everything.
In the absence of randomized trials, simple comparisons
are greeted with skepticism from unconvinced colleagues. We
are comparing apples and oranges! Treatment has been selec-
tive, so the treatment groups often differ importantly in base-
line characteristics, and these may account for differences we
attribute to treatment.
Fortunately, for nonrandomized comparisons, a break-
through technology now exists that under certain circum-
stances can adjust for selection factors and allow causal infer-
ences to be made from clinical experience. You need to
understand this new technology better.
Risk Factor Identification
Clinical question: What are the risk factors for death
after valve repair or replacement for degenerative mitral
valve disease?
Available data: Long-term systematic follow-up of
patients and numerous patient and procedure details.
Usual method (I hesitate to say simple, because it is not!):
Multivariable analysis. However, the best analyses are care-
fully crafted, intensely medically informed, and use “human”
directed variable selection strategies.3 The process is more art
than science.
Multivariable identification of risk factors may seem only a
technical statistical detail to surgeons. However, it is the sub-
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analysis.”8 The methodology accounts for correlation
among repeated measurements in individual patients, vari-
ables that relate to both the average effect and the nature of
the variability, measurement at irregular intervals, and cen-
soring. (The latter assumes that censoring is independent of
the outcome being analyzed, just as in survival analysis.)
Because both average response and variability are analyzed
simultaneously, the technology has been called “mixed
modeling.” The technique has been extended to dichoto-
mous and ordinal variables.
Thus, except under exceptional circumstances when
the techniques are similar, this new technology has virtu-
ally replaced former restrictive varieties of repeated-mea-
sures analysis.
For illustration, Figure 1A is a scattergram of mean
pressure gradient estimates from echocardiography across
aortic pericardial valves. Questions asked: (1) What is the
behavior pressure gradient across time? (2) What is the
influence of prosthesis size? (3) What other factors relate
to the gradient? These were opportunistically acquired
data points and may contain biases of assessment. Further,
most patients were dead by 18 years, and some had their
prosthesis explanted (censoring mechanisms). Import-
antly, Figure 1B illustrates that pressure gradients were
measured multiple times in some patients. How do we
make sense of such data?
Conceptually, imagine modeling each patient’s gradient
pattern across time. Then average the individual model param-
eters to obtain a global pattern. This is a simplistic but useful
notion of what the analysis is doing in a much more sophisti-
cated fashion.
Figure 1C shows the average response illustrating the
general evolution of mean gradient from the data and the
expected differences according to valve size.*
Let us shift from a continuous outcome to an ordered
categorical outcome in these same valve prosthesis
patients: aortic valve regurgitation (Figure 2). The
assumption is that patients progress across time from
lower grades of regurgitation to higher grades. Think of
Statistics for the Rest of Us Blackstone
*Banbury MK, Cosgrove DM, Thomas JD, Blackstone EH, Rajeswaran
J, Okies JE, et al. Hemodynamic stability over 17 years of the Carpentier-
Edwards aortic pericardial bioprosthesis. Unpublished data.
Figure 1C. Average evolution of mean gradient by valve size using
longitudinal data analysis. Symbols as in Figure 1A.
Figure 1B. The same depiction as in Figure 1A, but repeated
assessments in individual patients are connected. 
1B
1C
Figure 1. Echocardiographically estimated mean pressure gradi-
ent across stented bovine pericardial aortic valve prostheses.
Figure 1A. Scattergram of individual measurements. Dots are for
size 19 valves, circles for size 21, squares for size 23, triangles for
size 25, and x for size 29. Mean gradients were not measured for
size 27 valves. 
1A
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In addition to the average evolution across time, we can use
longitudinal data analysis methodology to identify risk factors
that either accelerate or retard the regurgitation process.
Much cardiothoracic surgery follow-up data resemble
these two examples. We need not settle for a simple average
or a listing of values at last follow-up (which usually per-
progression as a series of cascading leaking containers.
Imagine the first container (grade 0) gradually emptying
into the grade 1+ container, which in turn leaks into grade
2+, which leaks into grades 3+ and 4+. Then imagine, if
this were water leaking, graphing the level of water in
each container as time progresses. This is the conceptual
idea behind an ordinal outcome assessment.
Aortic regurgitation was assessed at the same time that
mean pressure gradients were measured for the patients
shown in Figures 1A through 1C. Some had a single
echocardiogram, but many had two or more. We used longi-
tudinal data analyses for ordinal outcomes to construct the
average evolution of aortic regurgitation shown in Figure 3.
To provide a sense of visual validation, we superimposed
the proportion of observations in each regurgitation grade
for broad time intervals. (For this visual validation, we have
ignored the fact that multiple observations may have been
made in the same patient, but the analysis shown by the
solid lines takes that into account.)
Although the graph has multiple lines and so is somewhat
intimidating, the picture portrays how the proportion of
patients with a competent prosthesis decreases across time as
the number of patients in grade 1 builds up. Grade 1 is just
beginning to peak at 15 years because few patients remain in
grade 0 to enter grade 1 and other patients are progressing to
grade 2 regurgitation. More severe grades of regurgitation
have already begun to develop in a few patients.
TABLE 1.  Balance in patient and selection characteristics
achieved by unbalancing number of cases in each propen-
sity ranked group
Study Factor present, n Factor absent, n
Long-term aspirin use
Quintile 1 113 1192
Quintile 2 194 1111
Quintile 3 384 922
Quintile 4 719 586
Quintile 5 1045 261
Natural selection: preoperative 
AF in degenerative MV disease
Quintile 1 2 225
Quintile 2 13 214
Quintile 3 32 195
Quintile 4 78 149
Quintile 5 162 66
OPCAB versus PCAB
Quintile 1 40 702
Quintile 2 71 671
Quintile 3 61 682
Quintile 4 90 652
Quintile 5 219 524
AF, Atrial fibrillation; MV, mitral valve; OPCAB, off-pump coronary artery
bypass; PCAB, on-pump coronary artery bypass.
Figure 3. Evolution of the various grades of aortic valve regurgita-
tion across stented bovine pericardial aortic valve prostheses
across follow-up time. The symbols for each regurgitation grade
represent summary raw data within intervals, ignoring repeated
measurements within patients. Dots are for grade 0, circles for
grade 1+, squares for grade 2+, and triangles for grades 3+ and 4+
(combined because of sparse information). The smooth lines are
model predictions for each regurgitant grade.
Figure 2. Diagram of the assumption that aortic regurgitation
across stented bovine pericardial aortic valve prostheses pro-
gresses from grade 0 to grade 1+, then to grade 2+, and finally to
grades 3+ and 4+.
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tains to median follow-up time), discarding repeated assess-
ment. The visual display may be more complex. But is this
not what we were wanting to know all along?
Accounting for Selection Factors in Nonrandomized
Comparisons
Few medical decisions are based solely on randomized clin-
ical trials. Rather, they are based on clinical observations,
experience, and judgment. It is unlikely that every decision
in the future can be based on randomized clinical trials. The
reasons are in part irrational, in part practical and econom-
ic, in part moral, and in part inherent in the weaknesses of
randomized clinical trials, particularly when end points are
in the distant future, during which time crossover and
changing conditions obscure the comparison. Some desired
comparisons of naturally occurring phenomena, such as
investigating the consequences of chronic atrial fibrillation,
then cannot be subjected to randomized trial.
We must acknowledge that simple comparisons of non-
randomized treatment have led us astray. This is because the
treatment is confounded by selection factors. Randomized
clinical trials eliminate this form of bias. However, random-
ized clinical trials are often designed so narrowly as to pre-
clude widespread generalization to routine clinical care. If,
instead, we are going to attempt to use clinical practice
information for making comparisons, the analytical method
must account for patient selection factors.
One method devised to account for patient selection is
matched comparison. The idea is to match patients in one
group with those in another on the basis of as many patient
characteristics as possible. Unfortunately, once one tries to
match more than two or three characteristics, it becomes
exceedingly difficult to identify matching pairs. This has
made many of us skeptical of matched comparisons. An
alternative has been multivariable analysis of outcomes in
which other variables modulating the outcome are account-
TABLE 2.  Comparison of patient characteristics in entire group of patients undergoing coronary artery bypass grafting
Characteristics On pump (n = 3231) Off pump (n = 481) P value
Demography
Age (mean ± SD) 64 ± 10.4 66 ± 11.3 <.001*
Men 2432 (75)† 328 (68) .001
Noncardiac comorbidity
Diabetes
Insulin treatment 443 (14) 50 (10) .05
Oral hypoglycemic treatment 619 (19) 88 (18) .7
Previous stroke 191 (5.9) 45 (9.4) .004
Carotid disease 456 (14) 106 (22) <.001
Peripheral vascular disease 435 (13) 86 (18) .009
Hypertension 2264 (70) 360 (75) .03
Left ventricular dysfunction .10
None 1878 (58) 291 (64)
Mild 648 (20) 82 (18)
Moderate 406 (13) 49 (11)
Severe 296 (9) 32 (7)
Not recorded 3 27
Coronary artery disease (≥50%)
Left main disease 691 (21) 108 (22) .6
LAD 2977 (92) 429 (89) .03
LCX 2593 (80) 306 (64) <.001
RCA 2725 (84) 334 (69) <.001
No. of diseased systems (≥50%) <.001
0 9 (0.3) 13 (2.7)
1 115 (3.6) 60 (12)
2 776 (24) 158 (33)
3 2324 (72) 250 (52)
Unreliable variable 881 (44) 93 (32) <.001
Purposely not used variable 1.32 ± 0.82 2.6 ± 0.62 <.001
SD, Standard deviation; LAD, left anterior descending coronary artery system; LCX, circumflex coronary artery system; RCA, right coronary artery system.
*Wilcoxon sum rank test.
†Presented as number (percent of column total).
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ed for, leaving any residual difference attributable to the
treatment. Some of us have thought this method was superi-
or to matching. Multivariable adjustment may work excel-
lently; however, there has been no way to verify that it has
worked and plenty of examples cited where it has not.
Breakthrough occurred in the early 1980s with an
important article by Rosenbaum and Rubin.9 They intro-
duced the idea of balancing scores, the simplest and
coarsest of which is the propensity score.10 The tech-
nique, aimed at drawing causal inference from unrandom-
ized comparison data, went largely unnoticed in an era of
governmental support for large multi-institutional ran-
domized clinical trials. This has changed. Beginning in
the mid-1990s, statisticians began using balancing scores,
and propensity scores in particular, in medicine and many
other disciplines that require comparisons.
Construction of a propensity score is not a foreign sub-
ject to cardiothoracic surgeons. We have often asked what
factors are associated with receiving one form of treatment
rather than another: transvalvular patch or not in tetralogy of
Fallot, one-stage versus two-stage management of cyanotic
babies, palliation versus aggressive therapy for brain metas-
tases, and so forth. In these analyses, the treatment received
is simply an event. Therefore, the usual probability-of-event
analyses to which we have become accustomed over the
past 30 years, such as logistic regression, are used to identi-
fy factors associated with what I will call “group member-
ship” (the treatment received).
On the surface, it may seem ludicrous to identify fac-
tors associated with group membership when, of course,
we know what treatment the patient has received!
However, this is no stranger than our trying to find com-
mon denominators of an event such as hospital mortality.
There, too, we know that the patient has died, but we are
trying to look at a large group of patients to discover the
general risk factors. In the case of examining group mem-
TABLE 3.  Comparison of patient characteristics in greedy matched groups undergoing coronary artery bypass grafting
Characteristics On pump (n = 406) Off pump (n = 406) P value
Demography 
Age (mean ± SD) 66 ± 11.3 66 ± 11 .9*
Men 284 (70)† 280 (69) .8
Noncardiac comorbidities
Diabetes
Insulin treatment 35 (8.6) 44 (11) .3
Oral hypoglycemic treatment 80 (20) 76 (19) .7
Previous stroke 23 (5.7) 38 (9.4) .05
Carotid disease 79 (19) 88 (22) .4
Peripheral vascular disease 50 (12) 74 (18) .02
Hypertension 295 (73) 300 (74) .7
Left ventricular dysfunction .7
None 252 (62) 245 (63)
Mild 81 (20) 77 (20)
Moderate 38 (9.4) 43 (11)
Severe 33 (8.2) 24 (6.2)
Not recorded 2 17
Coronary artery disease (≥50%)
Left main 93 (23) 91 (22) .9
LAD 359 (88) 372 (92) .1
LCX 282 (69) 279 (69) .8
RCA 310 (76) 315 (78) .7
No. of diseased systems (≥50%) .3
0 5 (1.2) 1 (0.2)
1 34 (8.4) 41 (10)
2 118 (29) 124 (31)
3 247 (61) 240 (59)
Unreliable variable 123 (48) 82 (33) <.001
Purposely not used variable 1.36 ± 0.80 2.5 ± 0.62 <.001
SD, Standard deviation; LAD, left anterior descending coronary artery system; LCX, circumflex coronary artery system; RCA, right coronary artery system.
*Wilcoxon sum rank test.
†Presented as number (percent of column total).
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pump coronary bypass grafting. In each case, patients are
sorted according to propensity score and then divided into
five equal numbered groups (quintiles). Notice that in the first
quintile, few patients have the factor present, but in the fifth
quintile, most have the factor present. Within each quintile,
patients are reasonably well matched, but patient characteris-
tics differ considerably between quintiles.
The propensity score (and, more generally, balancing
score) can be used for comparisons in several ways: (1)
propensity-matched pairs; (2) subset analysis according to
propensity score; and (3) multivariable adjustment. I10 shall
detail each of these in an upcoming editorial. In brief, in
propensity-matched pairs, patients are selected in pairs on
the basis of just one variable, the propensity score. In subset
analysis, the patients are sorted according to propensity
score, divided into a number of equal sized groups, and then
their characteristics and outcome are compared within these
subsets (illustrated in Table 1). In multivariable adjustment,
the propensity score and the indicator for treatment group
are incorporated into a general multivariable analysis of out-
come. Here I will illustrate just the first method, using the
propensity score in a matched-pair analysis.
Table 2 illustrates the problem of outcomes comparison
using clinical data: the two treatment groups are very dif-
ferent. The table compares patients according to whether
coronary bypass grafting was performed on pump or off
Statistics for the Rest of Us Blackstone
bership, we are attempting to identify selection factors
associated with a higher or lower propensity toward
receiving one treatment or the other.
Once one has identified the main factors, which are in
and of themselves of interest, one generally has a large
enough number of patients in the study to amplify the logis-
tic regression equation with essentially everything else
known about the patients. It does not matter that many P
values will be nonsignificant. All we are trying to do is to
account for as much selection information as possible.
Things are familiar to this point. Now a new idea is intro-
duced. The logistic regression analysis generates an equa-
tion. This equation is solved mathematically for each patient
by entering values for the factors in the propensity equation.
This yields a single propensity score for each patient. What
is then claimed is that if patients are now grouped according
to the magnitude of their propensity score, groups with sim-
ilar scores will appear to be reasonably well matched with
respect to all their characteristics.9
This truly extraordinary claim is based on observing what
is happening in using the propensity score. Basically, patient
characteristics are balanced at the expense of unbalancing n.
Table 1 illustrates this phenomenon for three different stud-
ies: long-term aspirin use in patients evaluated for known or
suspected coronary artery disease, chronic atrial fibrillation
in degenerative mitral valve disease, and off-pump versus on-
TABLE 4.  Frequency of occurrence (%) of variables selected in bootstrap analyses of the late hazard phase of death after
mitral valve repair or replacement for degenerative disease
No. of bootstrap analyses
Variable 1 5 10 55 100 250 500 1000
Demography
Age 100 100 100 100 99 99 99 99
Women 0 0 0 6 7 4 3 5
Noncardiac comorbidity
Bilirubin 0 40 20 16 12 10 10 10
BUN 100 40 60 72 76 78 77 78
Hypertension 0 0 10 6 6 5 6 6
Peripheral vascular disease 0 0 0 4 2 4 3 3
Smoker 0 0 0 6 8 9 11 10
Ventricular function
Ejection fraction 0 0 0 18 22 22 24 25
LV dysfunction (grade) 100 60 70 70 66 66 68 68
RV systolic pressure 100 20 10 10 8 8 8 8
Cardiac morbidity
Coronary artery disease 100 100 100 96 94 92 92 91
Anterior leaflet prolapse 100 80 90 82 82 84 85 85
Preoperative condition
NYHA class 100 20 20 30 32 34 33 36
Hematocrit 0 0 20 16 17 14 16 17
Experience
Date of operation 100 20 10 14 15 14 13 14
BUN, Blood urea nitrogen; LV, left ventricular; RV, right ventricular; NYHA, New York Heart Association.
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nisms of disease or treatment failure, useful inferences for
medical decision-making, for lifestyle modification, and for
programmatic decisions about avenues of further research
could be gleaned by nonspecific risk factor identification.13
A direct consequence of the idea, however, is that for any set
of potential variables that may be associated with outcome,
there is no unique set of risk factors that constitute the best
common denominators of disease or treatment failure.
Therefore, different persons analyzing the same data may
generate different sets of risk factors.
As a consequence, multivariable analysis for risk factors
has become an art that depends on expert medical knowledge
of the entity being studied, understanding the goals of the
research, knowledge of the variables and how they may relate
to the study goals as well as to one another, identifying the
quality and reliability of each variable, and devising different,
often sequential, analysis strategies appropriate to each
research question. Not all these issues of art or expertise can
disappear, but there are substantial aspects of multivariable
analysis that are yielding to science.
Dr David Naftel,4 in an important 1994 letter, addressed nine
aspects of multivariable analysis that contribute to obtaining
different models (sets of risk factors). These include using dif-
ferent statistical models, different approaches to missing data,
different management of variables with minimal information,
different treatment of correlated data, different coding of data,
different handling of apparently incorrect data, different vari-
able selection methods and criteria using P values, different
computer resources, and different appreciations of science. In
all these areas but one, incremental information has been gen-
erated over the past several years that is beginning to differenti-
ate poor techniques from reasonable techniques and from opti-
mal techniques. That one area remaining has been different
variable selection methodology, and it is an important one.
Part of the challenge is that variables may be thought to be
risk factors because they are associated with a small P value,
and other factors may be thought not to be risk factors
because of larger P values, but both opinions may be erro-
neous (type I and type II statistical errors, respectively).
There is need for a method that balances these two types of
error. Closely coupled with this is the need for a measure of
reliability of identification of the risk factors. Because one is
analyzing only a single set of data, and not many sets of data
about the same subject, reliability with which risk factors are
identified has been elusive.
Recently, breakthrough has occurred in risk factor selection
that promises to balance decision errors and quantify the relia-
bility of the variable selection process.16 The method belongs to
a class of new methods that has developed over the past 20 years.
In 1983, an astonishing article appeared in the lay press by Persi
Diaconis and Bradley Efron from Stanford University entitled,
“Computer-Intensive Methods in Statistics.”15 They indicated
that “most statistical methods in common use today were devel-
pump.* Patients undergoing off-pump bypass were older,
had higher creatinine values, had more carotid artery dis-
ease, and were more likely to be hypertensive than patients
whose bypass grafting was performed on pump. In con-
trast, patients who underwent on-pump bypass grafting
had more advanced symptoms, were more likely to have
diabetes, and had more right coronary artery disease and
left circumflex disease.
A propensity analysis was performed using 43 patient vari-
ables. The propensity score was then used to pair closely
matched patients.11,12 Only 406 of the 481 off-pump cases
could be matched well with cases undergoing on-pump surgery.
For the most part, the two groups of patients were well matched
on most variables (Table 3). Of some 73 comparisons, only two
differed at P < .05. Therefore, we believe comparison of treat-
ment outcomes has more validity in these well-matched
patients than it had in the unmatched comparison.
There are important limitations of balancing scores. First,
in some at least theoretical sense, each patient should have a
finite probability of receiving both treatments. If treatment is
rendered by systematic protocol, the treatment is so con-
founded with other elements of the protocol that there may be
no way to separate treatment effects from the constellation of
protocol-driven factors. For example, if one institution uses
technique A systematically and another institution uses tech-
nique B systematically, propensity score methodology may
well form groups of closely matched patients from each insti-
tution, but inferences about a treatment effect remain con-
founded with institutional differences.
A second limitation that differentiates this methodolo-
gy from randomized clinical trials is that it cannot take
into account unmeasured factors that cannot be ignored.
For this article, I tested this limitation. Tables 2 and 3 con-
tain two variables that were deliberately not taken into
account in propensity matching. The two groups are quite
unmatched with regard to both of these variables (Table
1). Propensity matching on other factors did not balance
the groups on these two factors (Table 1). This finding has
made me cautious of propensity matching based on only a
handful of variables.
When propensity matching is used, it is not uncommon to
find some unmatched patients: oranges among the apples.
They represent ends of the spectrum of a disease that are treat-
ed in a systematic fashion. It is a good idea to characterize
them and determine why treatment was systematic.
Transforming Multivariable Analysis from Art to
Science
A seminal contribution of the Framingham Study Investi-
gators was the idea that in the absence of identified mecha-
*Sabik JF, Gillinov AM, Blackstone EH, Vacha C, Houghtalling P,
Navia J, et al. Off pump techniques do not reduce major morbidity and
mortality of coronary artery bypass surgery. Unpublished data.
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oped between 1800 and 1930, when computation was slow and
expensive. Now computation is fast and cheap . . . . The new
methods are fantastic computational spendthrifts . . . . The pay-
off for such intensive computation is freedom from two limiting
factors that have dominated statistical theory since its begin-
nings: the assumption that the data conform to a bell-shaped
curve and the need to focus on statistical measures whose theo-
retical properties can be analyzed mathematically.”
Dr Efron and his group demonstrated that random sam-
pling with replacement from a data set to create a new data set,
repeated to generate perhaps thousands of new data sets, can
generate robust and accurate statistics without assumptions by
combining the information generated from these many data
sets. His group called the technique bootstrapping. They
named it bootstrapping after the expression “pulling yourself
up by your own bootstraps,” because it reflected the fact that
one could develop all the statistical testing necessary directly
from the actual data in hand by repeated sampling.
These techniques have been applied to entire analytical
processes, including multivariable analysis,14 and have been
called “bootstrap bagging.” In fact, one still has to pay atten-
tion to appropriate models, missing data, variable considera-
tions, very particularly to correlated variables, appropriate
strategy, and so forth, that remain part of a disciplined,
informed approach to the data. However, the variable selection
process is bootstrapped.
In practice, a carefully crafted set of variables is formulat-
ed that will be subjected to simple automated variable selec-
tion, such as forward stepwise selection, whereby the most
significant variables are entered one by one into a multivari-
able model. A specific P value criterion for entering and
retaining these variables is specified. Then, a random sample
of cases is selected, sometimes of the same sample size as the
original n, but often of somewhat smaller size as protection
against identifying rare patient subgroups as risk factors. A
completely automated analysis is performed, and the results of
it are stored. Then, another random set of cases is drawn from
the original data set, and analysis is performed. This resam-
pling of the original data set followed by analysis continues
perhaps hundreds and even thousands of times. Finally, the
frequency of occurrence of risk factors among these many
models is summarized. The frequency of occurrence general-
ly stabilizes after about 100 bootstrap analyses.
Of interest, the variables identified for every bootstrap data
set are usually different, a sobering revelation. However, it
soon becomes evident that some variables never are selected
and others seldom are selected. The variables that appear in
50% or more of models are claimed to be the reliable ones.
This phenomenon is illustrated in Table 4. Fifteen variables
were selected from among many being analyzed for the late
hazard phase of death after mitral valve repair or replacement
for degenerative disease. In analysis of the first bootstrap sam-
ple, 8 of these 15 variables were selected (only 5 of which
were found eventually to be reliable risk factors). By 100
analyses, although every variable had been identified as a risk
factor in at least two analyses, 5 variables dominated the
analyses, which we considered the reliable risk factors, 8
rarely appeared, and 2 appeared in 22% to 32% of analyses.
What happens in bootstrap bagging is similar to what is
seen in signal averaging, such as in visual evoked potentials:
noise becomes canceled out as the signal becomes amplified.
In the same way, many variables appear rarely in models, but
a few show up time and time again. One therefore can express
the reliability of identification of a given risk factor.
Bootstrap bagging, although demanding huge amounts of
computer cycles, removes much of the human arbitrariness
from multivariable analysis and provides another important
statistic: a measure of reliability of a risk factor. Thus, increas-
ingly we have been reporting not only the magnitude of the
effect, its variance, and its P value, but also its bootstrap relia-
bility. The technique appears to provide a balance between
selecting risk factors that are not reliable (type I error) and
overlooking variables that are reliable (type II error).
Barriers Remaining
What will we do with these breakthrough technologies that
have broken down important barriers to meaningful cardio-
thoracic clinical research? What I fear is that cardiothoracic
surgeons will presume these technologies will not be helpful,
but rather a new set of barriers to their understanding of clini-
cal data analysis reports.
These methods are no doubt complex. They require the
expertise of a collaborating statistical colleague. Un-
fortunately, we insist on doing our own statistics, content to
live with the simple answers rather than those that are most
revealing or most accurate. We must learn that we can under-
stand methods without having to push all the buttons!
A caveat is that you may find that your statisticians have
not kept up with these breakthrough developments in their
own field! They reinforce fallback to obsolete methods.
What is not ignorable is that the methods require high-
speed computing and dissemination of high-quality software.
Until popular operating systems incorporate true multithread-
ing, background bootstrapping at least on personal computers
will remain a nightmare.
All these barriers can be overcome but one: your lack of
understanding of the methodology. The purpose of this article
has been to help you understand these breakthrough statistical
methods better.
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